These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36121202)

  • 1. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
    Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
    Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
    Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain.
    Birtele M; Storm P; Sharma Y; Kajtez J; Wahlestedt JN; Sozzi E; Nilsson F; Stott S; He XL; Mattsson B; Ottosson DR; Barker RA; Fiorenzano A; Parmar M
    Development; 2022 Dec; 149(23):. PubMed ID: 36305490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing.
    Fiorenzano A; Sozzi E; Parmar M; Storm P
    Cells; 2021 Jun; 10(6):. PubMed ID: 34206038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
    de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
    Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.
    de Luzy IR; Niclis JC; Gantner CW; Kauhausen JA; Hunt CPJ; Ermine C; Pouton CW; Thompson LH; Parish CL
    J Neurosci; 2019 Nov; 39(48):9521-9531. PubMed ID: 31641054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell Profiling of Coding and Noncoding Genes in Human Dopamine Neuron Differentiation.
    Nilsson F; Storm P; Sozzi E; Hidalgo Gil D; Birtele M; Sharma Y; Parmar M; Fiorenzano A
    Cells; 2021 Jan; 10(1):. PubMed ID: 33445654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.
    Cooper O; Hargus G; Deleidi M; Blak A; Osborn T; Marlow E; Lee K; Levy A; Perez-Torres E; Yow A; Isacson O
    Mol Cell Neurosci; 2010 Nov; 45(3):258-66. PubMed ID: 20603216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Influence of Target Acquisition on Survival, Integration, and Phenotypic Maturation of Dopamine Neurons within Stem Cell-Derived Neural Grafts in a Parkinson's Disease Model.
    Moriarty N; Kauhausen JA; Pavan C; Hunt CPJ; de Luzy IR; Penna V; Ermine CM; Thompson LH; Parish CL
    J Neurosci; 2022 Jun; 42(25):4995-5006. PubMed ID: 35610045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
    Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
    Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons.
    Jo J; Xiao Y; Sun AX; Cukuroglu E; Tran HD; Göke J; Tan ZY; Saw TY; Tan CP; Lokman H; Lee Y; Kim D; Ko HS; Kim SO; Park JH; Cho NJ; Hyde TM; Kleinman JE; Shin JH; Weinberger DR; Tan EK; Je HS; Ng HH
    Cell Stem Cell; 2016 Aug; 19(2):248-257. PubMed ID: 27476966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.
    Niclis JC; Gantner CW; Alsanie WF; McDougall SJ; Bye CR; Elefanty AG; Stanley EG; Haynes JM; Pouton CW; Thompson LH; Parish CL
    Stem Cells Transl Med; 2017 Mar; 6(3):937-948. PubMed ID: 28297587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
    Sánchez-Danés A; Consiglio A; Richaud Y; Rodríguez-Pizà I; Dehay B; Edel M; Bové J; Memo M; Vila M; Raya A; Izpisua Belmonte JC
    Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dickkopf 3 Promotes the Differentiation of a Rostrolateral Midbrain Dopaminergic Neuronal Subset In Vivo and from Pluripotent Stem Cells In Vitro in the Mouse.
    Fukusumi Y; Meier F; Götz S; Matheus F; Irmler M; Beckervordersandforth R; Faus-Kessler T; Minina E; Rauser B; Zhang J; Arenas E; Andersson E; Niehrs C; Beckers J; Simeone A; Wurst W; Prakash N
    J Neurosci; 2015 Sep; 35(39):13385-401. PubMed ID: 26424886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
    Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
    Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.
    Patikas N; Ansari R; Metzakopian E
    Neurosci Res; 2023 Oct; 195():13-28. PubMed ID: 37271312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of
    Fiorenzano A; Birtele M; Wahlestedt JN; Parmar M
    Heliyon; 2021 Jan; 7(1):e06006. PubMed ID: 33532642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic 3D Combinatorial Generation of hPSC-Derived Neuromesodermal Organoids With Diverse Regional and Cellular Identities.
    Whye D; Wood D; Kim KH; Chen C; Makhortova N; Sahin M; Buttermore ED
    Curr Protoc; 2022 Oct; 2(10):e568. PubMed ID: 36264199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.
    Studer L
    Prog Brain Res; 2017; 230():191-212. PubMed ID: 28552229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.